After Laetrile, What?
- 17 June 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 306 (24) , 1482-1484
- https://doi.org/10.1056/nejm198206173062410
Abstract
Laetrile was moribund before Moertel et al. laid it to rest with the recent report of their prospective clinical trial.1 , 2 It had been replaced in popularity by an approach unusual in the annals of unorthodox cancer therapy — one that represents more of a challenge than did Laetrile or its predecessors. This is the "natural" approach to malignant disease, which emphasizes cure through purification and the body's capacity to heal itself. The currently popular alternative approach is rooted in homeopathic and naturopathic beliefs, Indian and Oriental philosophy, and 19th-century theories of intestinal putrefaction. Promoters often evoke the time-worn conspiracy dogma, . . .Keywords
This publication has 2 references indexed in Scilit:
- A Clinical Trial of Amygdalin (Laetrile) in the Treatment of Human CancerNew England Journal of Medicine, 1982
- Closing the Books on LaetrileNew England Journal of Medicine, 1982